Vitrolife AB (publ) (STO:VITR)

Market Cap	21.42B
Revenue (ttm)	3.61B
Net Income (ttm)	498.00M
Shares Out	135.42M
EPS (ttm)	3.67
PE Ratio	43.11
Forward PE	31.63
Dividend	1.10 (0.70%)
Ex-Dividend Date	Apr 30, 2025

Volume	105,850
Average Volume	251,003
Open	156.30
Previous Close	156.30
Day's Range	156.20 - 163.10
52-Week Range	142.90 - 268.00
Beta	1.83
RSI	50.82
Earnings Date	Jul 17, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR